Skip to main content
SpringerLink
Log in

Phytomedikation in der Urologie

La phytothérapie en urologie

  • Extended Abstract
  • Published:
Urologie in der Praxis Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Weiterführende Literatur

  1. Albrecht U et al (2007) A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing tropaeoli majoris herba (nasturtium) and armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin 23(10):2415–2422

    Article  PubMed  Google Scholar 

  2. Antoniou V et al (2023) Role of phytotherapy in the management of BPH: a summary of the literature. J Clin Med 12(5):1899–1828

    Article  PubMed  PubMed Central  Google Scholar 

  3. Boeing T et al (2021) Phytochemistry and pharmacology of the genus equisetum (equisetaceae): a narrative review of the species with therapeutic potential for kidney diseases. Evid Based Complement Alternat Med 2021:6658434

    Article  PubMed  PubMed Central  Google Scholar 

  4. Butler DSC et al (2023) Phytotherapy (BNO 1045) of acute lower uncomplicated urinary tract infection in women normalizes local host responses. Urol Int 107(8):778–784

    Article  CAS  PubMed  Google Scholar 

  5. Cai T et al (2020) Comparison of serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis. Am J Mens Health 14(2):1557988320905407

    Article  PubMed  PubMed Central  Google Scholar 

  6. Csikós E et al (2021) Treatment of benign prostatic hyperplasia by natural drugs. Molecules 26(23):7141

    Article  PubMed  PubMed Central  Google Scholar 

  7. De Nunzio C et al (2020) Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia. World J Urol 38(11):2771–2779

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dhouibi R et al (2020) Screening of pharmacological uses of Urtica dioica and others benefits. Prog Biophys Mol Biol 150:67–77

    Article  CAS  PubMed  Google Scholar 

  9. Franco JV et al (2019) Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev 10(10):CD12552

    PubMed  Google Scholar 

  10. Gurley BJ et al (2004) In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 76(5):428–440

    Article  PubMed  Google Scholar 

  11. Heidari-Soreshjani S et al (2017) Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review. J Nephropathol 6(3):254–263

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hosseini A et al (2023) Protective effects of pomegranate (Punica granatum) and its main components against natural and chemical toxic agents: a comprehensive review. Phytomedicine 109:154581

    Article  CAS  PubMed  Google Scholar 

  13. Hou PJ et al (2024) Integrated traditional herbal medicine for recurrent urinary tract infection treatment and follow-up: a meta-analysis of randomized controlled trials. J Ethnopharmacol 321:117491

    Article  CAS  PubMed  Google Scholar 

  14. Jaladat AM et al (2015) Botanicals: an alternative remedy to radiotherapy-induced dysuria. Complement Ther Med 23(1):90–99

    Article  PubMed  Google Scholar 

  15. Kirschner-Hermanns R et al (2019) WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH. Ther Adv Urol 11:1756287219879533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Krakhotkin DV et al (2022) A prospective, observational study of use combination silodosin 8 mg plus serenoa repens, urtica dioica, cucurbita pepo (rotaprost) compared with silodosin 8 mg alone in treatment patients with benign prostate hyperplasia. Clin Complement Med Pharmacol 2(3):100043

    Article  Google Scholar 

  17. Lau et al (2018) Phytotherapie bei katheterassoziierten Harnwegsinfekten. Beobachtungsstudie zur Wirksamkeit und Sicherheit einer fixen Kombination mit Kapuzinerkressenkraut und Meerrettichwurzel. Urologe A 57(12):1472–1480

    Article  PubMed  Google Scholar 

  18. Leisegang K et al (2022) A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia. Phytomedicine Plus 2(1):100153

    Article  Google Scholar 

  19. Markowitz JS et al (2003) Multiple doses of saw palmetto (serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 74(6):536–542

    Article  CAS  PubMed  Google Scholar 

  20. Martynyuk L et al (2014) Effect of the herbal combination Canephron N on diabetic nephropathy in patients with diabetes mellitus: results of a comparative cohort study. J Altern Complement Med 20(6):472–478

    Article  PubMed  Google Scholar 

  21. Mo B, Hensel (2023) Alte Drogen – neue Erkenntnisse? Neue Strategien zur adjuvanten Behandlung von Harnwegsinfekten mit Schachtelhalmkraut. Z Phytother 44:113–120

    Article  Google Scholar 

  22. Nausch B et al (2019) The standardized herbal combination BNO 2103 contained in Canephron® N alleviates inflammatory pain in experimental cystitis and prostatitis. Phytomedicine 60:152987

    Article  PubMed  Google Scholar 

  23. Pfister T, Saller R et al (2014) Heilkräuter im Garten. Haupt Verlag, Bern

    Google Scholar 

  24. Rajput P et al (2018) Phytochemical and pharmacological importance of genus urtica—a review. Int J Pharm Sci Res 9(4):1387–1396

    CAS  Google Scholar 

  25. Ratnam N et al (2017) A review of Cucurbita pepo. Int J Pharmacogn Phytochem Res 9(9):1190–1194

    Google Scholar 

  26. Rostock M, Saller R (2021) Phytotherapie und “herbal medicine”. Complement Med Res 28(4):281–283

    Article  PubMed  Google Scholar 

  27. Sabadash M, Shulyak A (2017) Canephron® N in the treatment of recurrent cystitis in women of child-bearing age: a randomised controlled study. Clin Phytosci 3:9

    Article  Google Scholar 

  28. Saller R (2022) Supportivmedizin, multimorbidität und phytotherapie. Z Phytother 43(Suppl 1):56–57

    Google Scholar 

  29. Saller R et al (1995) Phytotherapie. Klinische, pharmakologische u. pharmazeutische Grundlagen. Haug Verlag, Heidelberg

    Google Scholar 

  30. Saller R et al (2011) Antiinflammatorisch wirksame Phytotherapeutika und ihr mögliches Potential bei tumorkranken Menschen. Forsch Komplementmed 18:203–212

    Article  PubMed  Google Scholar 

  31. Saller R, Rostock M (2012) Multimorbidität und multi-target-therapie in der phytotherapie. Praxis 101:1637–1642

    Article  CAS  PubMed  Google Scholar 

  32. Samarinas M et al (2018) Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction. Prostate Cancer Prostatic Dis 21(2):161–167

    Article  CAS  PubMed  Google Scholar 

  33. Sandhu NS et al (2010) Equisetum arvense: pharmacology and phytochemistry—a review. Asian J Pharm Clin Res 3:146–150

    MathSciNet  CAS  Google Scholar 

  34. Schilcher H, Kammerer S (2007) Leitfaden Phytotherapie, 3. Aufl. Urban & Fischer, München

    Google Scholar 

  35. Schilcher H, Vahlensieck W (2001) Phytotherapie in der Urologie Bd. 2. Hippokrates Verlag, Stuttgart

    Google Scholar 

  36. Shi S, Klotz U (2012) Drug interactions with herbal medicines. Clin Pharmacokinet 51(2):77–104

    Article  CAS  PubMed  Google Scholar 

  37. Suter A et al (2013) Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial. Phytother Res 27(2):218–226

    Article  PubMed  Google Scholar 

  38. Thederan I, Rostock M (2023) Komplementärmedizin in der Uroonkologie. In: Michel et al (Hrsg) Die Urologie. Springer Reference Medizin

    Google Scholar 

  39. Utz S et al (2023) Phytotherapeutische Optionen zur Behandlung von akuten Harnwegsinfekten und interstitieller Zystitis. Z Phytother 44:250–256

    Article  Google Scholar 

  40. van Wietmarschen H et al (2022) Effectiveness of herbal medicines to prevent and control symptoms of urinary tract infections and to reduce antibiotic use: a literature review. Integr Med Res 11(4):100892

    Article  PubMed  PubMed Central  Google Scholar 

  41. Villa G et al (2022) Phytotherapy in urological benign disease: a systematic review. Int J Urol Nurs 16(3):174–195

    Article  Google Scholar 

  42. Wagenlehner FM et al (2018) Non-antibiotic herbal therapy (BNO 1045) versus antibiotic therapy (fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre, non-inferiority phase III trial. Urol Int 101(3):327–336

    Article  CAS  PubMed  Google Scholar 

  43. Wawrysiuk S et al (2022) Postoperative prevention of urinary tract infections in patients after urogynecological surgeries-nonantibiotic herbal (canephron) versus antibiotic prophylaxis (fosfomycin trometamol): a parallel-group, randomized, noninferiority experimental trial. Pathogens 12(1):27

    Article  PubMed  PubMed Central  Google Scholar 

  44. Williams G et al (2023) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 11(11):CD1321

    PubMed  Google Scholar 

  45. Yarnell E, Abascall K (2005) Natural approaches to treating chronic prostatitis and chronic pelvic pain syndromes. Altern Complement Ther 11(5):246–251

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Albisstr. 20, Postfach, 8038, Zürich, Schweiz

    Reinhard Saller

Authors
  1. Reinhard Saller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reinhard Saller.

Ethics declarations

Interessenkonflikt

R. Saller gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saller, R. Phytomedikation in der Urologie. Urol. Prax. 26, 17–21 (2024). https://doi.org/10.1007/s41973-024-00243-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41973-024-00243-7

Search

Navigation